Insight

Philippe Spiess: The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma

oncologynewscentral.com

Dec 26, 2024, 12:53

Philippe Spiess: The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma

Philippe Spiess, Assistant Chief of Surgery and Senior Member, Department of GU Oncology at Moffitt Cancer Center, shared a post on X:

“The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN) – ScienceDirect.”

The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN)

Authors: Gianpaolo P. Carpinito, Thomas Gerald, Patrick J. Hensley, Austin J. Martin, Maximilian Pallauf, Jonathan Pham, Roger Li, Aaron M. Potretzke, Philippe E. Spiess, Nirmish Singla, Jay D. Raman, Jonathan Coleman, Surena F. Matin, Vitaly Margulis

Philippe Spiess

Aaron M. Potretzke Austin J. Martin cancer Gianpaolo P. Carpinito Jay D. Raman Jonathan Coleman Jonathan Pham Maximilian Pallauf Nirmish Singla OncoDaily Oncology Patrick J. Hensley Philippe E. Spiess Philippe Spiess Roger Li Surena F. Matin Thomas Gerald urothelial carcinoma Vitaly Margulis

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth